Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer

Arthritis and Rheumatism

Volumn 52, Issue 3, 2005, Pages 929-939

  Leclerc, Nathalie ^a   Noh, Tommy ^a   Khokhar, Arvinder ^a   Smith, Elisheva ^a   Frenkel, Baruch ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; LUCIFERASE; MESSENGER RNA; OLIGONUCLEOTIDE; OSTEOCALCIN; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR EGR 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; DNA PROTEIN COMPLEX; DNA RESPONSIVE ELEMENT; ENHANCER REGION; EXTRACELLULAR MATRIX; FIBROBLAST; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; GLUCOCORTICOID RESPONSE ELEMENT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 2; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION; GLUCOCORTICOIDS; MICE; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOCALCIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 14944356482     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20872     Document Type: Article

References (58)

1. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
2. Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 2002;966:73-81.
3. Rubin MR, Bilezikian JP. Clinical review 151: the role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 2002;87:4033-41.
4. Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 2003;18:1186-97.
5. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.
6. Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle: dissociation of cyclin A-cdk2 from E2F4-p130 complexes. J Biol Chem 2000;275:19992-20001.
7. Smith E, Coetzee GA, Frenkel B. Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3β. J Biol Chem 2002;277:18191-7.
8. Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella M. Reduction in transforming growth factor β receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 1998;273:4892-6.
9. Delany AM, Gabbitas BY, Canalis E. Cortisol downregulates osteoblast α 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem 1995;57:488-94.
10. Delany AM, Jeffrey JJ, Rydziel S, Canalis E. Cortisol increases interstitial collagenase expression in osteoblasts by post-transcriptional mechanisms. J Biol Chem 1995;270:26607-12.
11. Lian JB, Shalhoub V, Aslam F, Frenkel B, Green J, Hamrah M, et al. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 1997;138:2117-27.
12. Zalavras C, Shah S, Birnbaum MJ, Frenkel B. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Expr 2003;13:221-35.
13. Lian JB, Stein GS, Stein JL, van Wijnen AJ. Osteocalcin gene promoter: unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem Suppl 1998;30-31: 62-72.
14. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-52.
15. Kerner SA, Scott RA, Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci U S A 1989;86:4455-9.
16. Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy ML, Eisman JA. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 1989;246: 1158-61.
17. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, et al. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 1995;34:13125-32.
18. Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 1995;15:1858-69.
19. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 1996;93:4968-73.
20. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54.
21. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
22. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-71.
23. Ikeda T, Kohno H, Yamamuro T, Kasai R, Ohta S, Okumura H, et al. The effect of active vitamin D3 analogs and dexamethasone on the expression of osteocalcin gene in rat tibiae in vivo. Biochem Biophys Res Commun 1992;189:1231-5.
24. Cosman F, Nieves J, Herbert J, Shen V, Lindsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res 1994;9:1097-105.
25. Stromstedt PE, Poellinger L, Gustafsson JA, Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol Cell Biol 1991;11:3379-83.
26. Morrison N, Eisman J. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J Bone Miner Res 1993;8:969-75.
27. Meyer T, Gustafsson JA, Carlstedt-Duke J. Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol 1997;16:919-27
28. Aslam F, Shalhoub V, van Wijnen AJ, Banerjee C, Bortell R, Shakoori AR, et al. Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Mol Endocrinol 1995;9:679-90
29. Heinrichs AA, Bortell R, Rahman S, Stein JL, Alnemri ES, Litwack G, et al. Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter. Biochemistry 1993;32:11436-44.
30. Leclerc N, Luppen CA, Ho VV, Nagpal S, Hacia JG, Smith E, et al. Gene expression profiling of glucocorticoid-inhibited osteoblasts. J Mol Endocrinol 2004;33:175-93
31. Luppen CA, Leclerc N, Noh T, Barski A, Khokhar A, Boskey AL, et al. Brief rhBMP-2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 2003;278:44995-5003.
32. Lian JB, Stein GS, Aubin JE. Bone formation: maturation and functional activities of osteoblast lineage cells. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research; 2003. p. 13-28.
33. Desbois C, Hogue DA, Karsenty G. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem 1994;269:1183-90.
34. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 2001;80:424-40.
35. Meyer T, Carlstedt-Duke J, Starr DB. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 1997;272:30709-14.
36. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 1998;93:487-90.
37. Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 2001;276:29603-10.
38. Tenenbaum HC, Heersche JN. Dexamethasone stimulates osteogenesis in chick periosteum in vitro. Endocrinology 1985;117: 2211-7.
39. Leboy PS, Beresford JN, Devlin C, Owen ME. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 1991;146:370-8.
40. Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, et al. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 1992;50:425-40.
41. Swirnoff AH, Milbrandt J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol 1995; 15:2275-87.
42. Banerjee C, Stein JL, van Wijnen AJ, Frenkel B, Lian JB, Stein GS. Transforming growth factor-β 1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology 1996;137:1991-2000.
43. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 1999;22:167-73.
44. Beckmann AM, Wilce PA. Egr transcription factors in the nervous system. Neurochem Int 1997;31:477-510.
45. Khachigian LM, Collins T. Early growth response factor 1: a pleiotropic mediator of inducible gene expression. J Mol Med 1998;76:613-6.
46. McMahon AP, Champion JE, McMahon JA, Sukhatme VP. Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. Development 1990;108:281-7.
47. Sukhatme VP. The Egr transcription factor family: from signal transduction to kidney differentiation. Kidney Int 1992;41:550-3.
48. Liebermann DA, Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene 2002;21: 3391-402.
49. Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, et al. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 1993;75:1199-214.
50. Swiatek PJ, Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 1993;7:2071-84.
51. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, et al. Krox-20 controls myelination in the peripheral nervous system. Nature 1994;371: 796-9.
52. Levi G, Topilko P, Schneider-Maunoury S, Lasagna M, Mantero S, Cancedda R, et al. Defective bone formation in Krox-20 mutant mice. Development 1996;122:113-20.
53. Thesingh CW, Groot CG, Wassenaar AM. Transdifferentiation of hypertrophic chondrocytes into osteoblasts in murine fetal metatarsal bones, induced by co-cultured cerebrum. Bone Miner 1991; 12:25-40.
54. Ichikawa H, Itota T, Torii Y, Inoue K, Sugimoto T. Osteocalcin- immunoreactive primary sensory neurons in the rat spinal and trigeminal nervous systems. Brain Res 1999;838:205-9.
55. De S, Shuler CF, Turman JE Jr. The ontogeny of Krox-20 expression in brainstem and cerebellar neurons. J Chem Neuroanat 2003;25:213-26.
56. Helvering LM, Sharp RL, Ou X, Geiser AG. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 2000;256:123-38.
57. Heegaard AM, Gehron Robey P, Vogel W, Just W, Widom RL, Scholler J, et al. Functional characterization of the human biglycan 5′-flanking DNA and binding of the transcription factor c-Krox. J Bone Miner Res 1997;12:2050-60.
58. Galera P, Park RW, Ducy P, Mattei MG, Karsenty G. c-Krox binds to several sites in the promoter of both mouse type I collagen genes: structure/function study and developmental expression analysis. J Biol Chem 1996;271:21331-9.